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Abstract
Tip110, an important regulator of several oncogenic proteins, was significantly downregulated in human metastatic
melanoma cells exposed to a hypoxic condition. Therefore, in this study, we set to determine whether differential
expression of Tip110 could be an important indicator for melanoma tumorigenesis and metastasis. We found that
in melanoma, but not in other cancer types, Tip110 knockdown enhanced significant expression and secretion of
IL-8 and melanoma cells invasions. This induction was further potentiated under hypoxia and by inflammatory
cytokine and found independent of TNF-α autocrine signaling. We further showed that Tip110 knockdown-
mediated IL-8 induction involved IL-8 mRNA stability. Furthermore, the transcriptomic profiling data and survival
from 455 melanoma patients demonstrated that the correlation between Tip110 expression and the clinical outcomes
in melanoma was stage-dependent. These findings uncover important roles of Tip110 in melanoma tumorigenesis and
metastasis through regulation of IL-8 and hope to provide new clues for future therapeutic strategies.
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Main text
Malignant melanoma is an aggressive form of skin can-
cer and one of the leading causes of death in the United
States. The demonstration of an increased incidence of
metastasis at sites of inflammation supports the import-
ant role of inflammatory cytokines in the pathogenesis
of tumor growth and metastasis. Among these cytokines
is interleukin-8 (IL-8), which is well documented for its
important roles in melanoma tumorigenesis and metas-
tasis [1]. IL-8 is normally induced and secreted by a di-
verse range of cells in response to pathologic stresses. Its
serum levels in patients are significantly elevated and are
correlated with advanced disease stage and poor progno-
sis. Thus, identification of the molecular players regulat-
ing IL-8, and in return promoting melanoma initiation
and progression, will provide new clues for possible
therapeutic strategies against melanoma.
HIV-1 Tat-interacting protein (Tip110), also known as
squamous cell carcinoma antigen recognized by T cells 3
(SART3), is a multifaceted nuclear protein and has been
shown to function in tumor antigenicity, regulation of
gene transcription, mRNA synthesis, stem cell prolifera-
tion and differentiation, and embryogenesis [2]. We and
others have reported that Tip110 interacts with and/or
regulates several oncogenic proteins [2]. The high ex-
pression level of Tip110 has been found in a number of
malignant tumor cell lines and cancerous tissues [2].
However, exposure of highly metastatic melanoma cells
to hypoxia led to a significant downregulation of Tip110
together with TP53 in both in vitro and in a melanoma
cancer bone metastasis mouse model [3]. Also, Tip110
expression was found to be dysregulated and correlated
with a metastatic phenotype in melanoma and lung
adenocarcinoma [4, 5]. Therefore, it is plausible that dif-
ferential expression of Tip110 could be an indicator for
melanoma tumorigenesis.
Here, we demonstrated that Tip110 contributed to the
regulation of the expression of IL-8 in melanoma cells
and that the expression level of Tip110 had a prognostic
value for melanoma patients. Furthermore, we identi-
fied the potential mechanism underlying the Tip110
knockdown-induced IL-8 expression.
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Results and discussion
Tip110 knockdown induced IL-8 expression in melanoma
with and without stimuli
Many alterations in tumor cells have been implicated as
contributing factors to the tumor progression and me-
tastasis. These changes include phenotypic characteris-
tics such as autocrine expression of cytokines/growth
factors and oncogenes or inactivation of tumor suppres-
sor genes and loss of responsiveness to inhibitory cyto-
kines/growth factors. Several reports had shown that
human melanoma cells grown in cultures express and
secrete numerous cytokines/growth factors either consti-
tutively or upon induction [6]. In addition, our previous
studies have shown a significant reduction of Tip110
together with TP53 expression in melanoma cells ex-
posed to a hypoxic condition [3]. Therefore, we exam-
ined the expression of selected inflammatory cytokines
and growth factors that are important during melanoma
progression, metastasis, and survival, in the context of
limited Tip110 expression [6]. Since TNF-α is involved
in the biosynthesis of many other cytokines, we specu-
lated that TNF-α treatment would potentiate any effect
that could be exerted by Tip110 knockdown. The results
showed that Tip110 knockdown led to significant
up-regulation of both IL-8 and TNF-α mRNA with and
without TNF-α treatment (Fig. 1a). A moderate increase
was found with IL-1β. Furthermore, the kinetic and the
level of IL-8 mRNA expression pattern with Tip110
knockdown and TNF-α treatment was different from
TNF-α and IL-1β expression at different time points
(Additional file 1: Figure S1A-C) indicating that IL-8 in-
duction by Tip110 knockdown in melanoma cells is
more likely independent of autocrine TNF-α and IL-1β
regulations. Induction of IL-8 by Tip110 knockdown
was also observed in other tested melanoma cell lines
(Additional file 1: Figure S2A-D), while no such effect
was observed in the cell lines from other cancer types
(Additional file 1: Figure S2E-I) except for non-small-cell
lung cancer cells, H1299, but the magnitude of IL-8 induc-
tion was relatively small compared to that in melanoma
cells with TNF-α treatment (Additional file 1: Figure S2J).
IL-8 mRNA is highly expressed in hypoxic areas of
several tumors including malignant melanoma, glioblast-
oma and ovarian carcinoma [1]. Thus, we examined the
expression level of selected cytokines in response to a se-
vere hypoxic condition and Tip110 knockdown. qRT-PCR
analysis revealed that hypoxia-induced up-regulation of
IL-8 was significantly enhanced by Tip110 knockdown in
melanoma (Fig. 1b). Unlike IL-8, the expression of TNF-α
and IL-1β in response to hypoxia and Tip110 knockdown
was reduced (Fig. 1c and d). In addition, Tip110 expression
was suppressed in the core tumor and presumably severe
hypoxic area of mouse bone metastasis tissues obtained by
inoculating metastatic melanoma 1205Lu ([3] and Fig. 1e).
Tip110 knockdown in 1205Lu cells increased IL-8
protein expression and stability compared to control
transfected cells by using cycloheximide (CHX) chase
assay (Fig. 1f ). Using ELISA assays, we also detected
increased levels of IL-8 in the conditioned media from
Tip110-knockdown 1205Lu cells with and without
TNF-α treatment (Fig. 1g). Furthermore, conditioned
media of Tip110-knockdown cells significantly increased
the invasiveness of melanoma cells (Fig. 1h). These re-
sults suggest that Tip110 downregulation in melanoma
cells leads to enhanced cell invasion, likely through
induction of IL-8 production and release as a growing
number of studies have shown that IL-8 is associated
with tumor cells migration and invasion [1].
Tip110 regulated IL-8 mRNA stability
The regulation of IL-8 expression involves both transcrip-
tional and posttranscriptional mechanisms [7]. Tip110
knockdown showed modest activation of the IL-8
promoter activity (Fig. 2a) indicating that induction of
IL-8 by Tip110 knockdown does not solely rely on the
IL-8 transcriptional activity. IL-8 could also potentially be
induced in cancer cells at the level of RNA synthesis and/
or mRNA stability [7]. Considering the role of Tip110 in
RNA processing [2], we investigated whether Tip110
knockdown would induce IL-8 through affecting the pro-
cessing of IL-8 gene transcripts and their stability. Using
specific primer sets (Fig. 2b), which specifically distinguish
IL-8 pre-mRNA and mature mRNA, we found that in
contrast to increases of the IL-8 pre-mRNA, the IL-8 ma-
ture mRNA was disproportionally increased in si-Tip110-
transfected cells (Fig. 2c). These results indicate that
Tip110 likely regulates IL-8 mRNA stability rather than
IL-8 pre-mRNA synthesis. To further address this possi-
bility, we performed an actinomycin D (ActD) chase assay.
The results showed that Tip110 knockdown significantly
prolonged half-life of the IL-8 mRNA compared to the
control (Fig. 2d and e). Previously, we showed that Tip110
knockdown up-regulated TNF-α mRNA (Fig. 1). There-
fore, we examined whether Tip110 would affect TNF-α
mRNA stability in a similar fashion to the IL-8. Interest-
ingly, TNF-α mRNA was highly unstable by knockdown
Tip110 (Fig. 2f and g), although the initial mRNA level at
0-h time point was much higher.
Since the p38 MAPK signaling pathway is known to
play a major role in IL-8 post-transcriptional regulation
and mRNA stability [7], we determined the roles of
Tip110 knockdown regulation of IL-8 transcript levels.
The results showed that treatment of cells with p38
MAPK signaling inhibitor led to significant attenuation of
IL-8-up-regulation at the mRNA level in Tip110 knocked
down cells (Fig. 2h). These results demonstrated that
Tip110 knockdown specifically stabilized and sustained
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Fig. 1 Negative correlation between Tip110, and IL-8 expression, secretion and melanoma cell invasion. a. Melanoma cancer cells 1205Lu were
transfected with either si-Ctrl or si-Tip110, cultured for 48 h, treated with 10 ng/ml of TNF-α for 4 h, and harvested for total RNA isolation.
qRT-PCR was performed to determine the mRNA expression of the indicated proteins. Knockdown of Tip110 protein was confirmed by Western
blotting (inset panel). b-d. 1205Lu were transfected same as above, cultured under severe hypoxia (0.3% O2) for 48 h, and harvested for total RNA
isolation and qRT-PCR to determine the (b) IL-8, (c) TNF-α and (d) IL-1β mRNA level. β-actin was included in the qRT-PCR and used as a relative
reference. The mRNA levels in the cells transfected with si-Ctrl and untreated with TNF-α were set to 1. a-d. # P < 0.05, ## P < 0.01, ### P < 0.001
compare to si-RNA untreated or normoxia control (si-Ctrl); ** P < 0.01, *** P < 0.001; 2-way ANOVA. e Mouse osteolytic bone metastasis tissues
were obtained by inoculating 1205Lu into bones of athymic nude mice. Longitudinal sections of control or metastasis bone were prepared and
immunostained for Tip110 and IL-8 protein expression. DAPI was used to visualize the nuclear DNA. T; tumor core region. f. 1205Lu were
transfected with si-Tip110 or si-Ctrl, treated with cycloheximide (CHX) for 0, 5, 10, 20, 40 or 80 min, and harvested for cell lysates and Western
blotting for Tip110 and IL-8 protein expression. β-actin was used as loading control. g. Cells were transfected and treated with TNF-α as stated
above. Cell culture supernatants were collected 24 h post TNF-α treatment and analyzed for IL-8 using a human IL-8-specific ELISA kit. ## P < 0.01,
### P < 0.001, compare to si-RNA untreated control (si-Ctrl); ** P < 0.01; 2-way ANOVA. h. si-Tip110 or si-Ctrl-transfected 1205Lu were seeded on a
24-well BioCoat™ Matrigel® invasion chamber with 8.0 μm PET membrane permeable supports. Media containing 0.1 and 10% FBS was used as
the negative (Neg), and positive (Pos) controls, respectively. Conditioned media from si-Ctrl and si-Tip110 transfected cells contained 0.1% FBS
were incubated for 16 h. Invaded cells were counted in 10 individual fields, and phase contrast images at 1× and 40× were captured. ** P < 0.01;
Student t-test. These results represent three independent experiments and the data presented as the mean ± SE. UT; Untreated
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the IL-8 gene transcripts, most likely through p38 MAPK
signaling.
Tip110 has the ability to recognize and bind to RNA,
and early studies have revealed that Tip110 plays a role
in the regulation of mRNA synthesis [2]. However,
Tip110 knockout in zebrafish can trigger compensatory
responses by up-regulating other mRNA synthesis re-
lated components [8]. Unexpectedly, in Tip110 knock-
down cells, we found an increase in IL-8 mRNA after
short-time exposure to ActD (Fig. 2d and e). We specu-
late that the unexpected findings may be due to robust
and high kinetics rate of IL-8 mRNA synthesis compared
to TNF-α mRNA in the context of a limited amount of
Tip110. Indeed, It has been shown in primary human
monocytes and macrophages that there is a much stron-
ger and sustained novel type of IL-8 mRNA stabilization
compared to TNF-α mRNA [9]. The (AU)-rich sequence
in the 3’-UTR of the IL-8 gene has been suggested to
Fig. 2 Effects of Tip110 knockdown on the IL-8 mRNA stability. a. 1205Lu were transfected with pIL-8.Luc.pro reporter vector plus si-Tip110 and
si-Ctrl and cultured for 48 h. The cells were treated with 10 ng/ml TNF-α for 20 h. pTK-βgal was used to normalize the transfection efficiency
variations among all transfections. ### P < 0.001 compare to si-RNA untreated control. *** P < 0.001; 2-way ANOVA. b. Schematic for the primer
sets on the IL-8 (indicated by arrow) used for qRT-PCR to determine the levels of IL-8 pre-mRNA and mRNA. c. 1205Lu were transfected with
si-Tip110 or si-Ctrl, cultured for 48 h, and harvested for total RNA isolation and qRT-PCR to determine the level of IL-8 pre-mRNA and mRNA. The
pre-mRNA levels in si-Ctrl-transfected cells were set to 1. ### P < 0.001, compare to si-Ctrl pre-mRNA, *** P < 0.001; 2-way ANOVA. d-g. 1205Lu
were transfected same as above, treated with 5 μg/ml actinomycin D (ActD) for 0, 2, 3, 6, 8, or 12 h, and harvested for RNA isolation and qRT-PCR
to determine the mRNA levels of IL-8 (d) and TNF-α (f). β-actin and GAPDH were included in the qRT-PCR and used as a relative reference. The
mRNA levels of si-Ctrl-transfected cells at 0-time point were set to 1. ** P < 0.01, *** P < 0.001; Student t-test. The percentage of the remaining
IL-8 mRNA (e) and TNF-α mRNA (g) were calculated by setting their respective mRNA level of the transfected cells at 0 h to be 100. The dashed
lines indicated the 50% mRNA half-life. h. 1205Lu were transfected as above, and treated with 5 μM p38 MAPK inhibitor SB203580, or the
vehicle control DMSO for 5 h, and harvested for RNA isolation and qRT-PCR for the IL-8 mRNA level. ### P < 0.001, compare to si-Ctrl
control, *** P < 0.001; 2-way ANOVA. All the data are representative of triplicate independent experiments and the data presented as the
mean ± SE. UT, Untreated
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contribute to its post-transcriptional regulation [10].
Therefore, it is possible that Tip110 targets the 3’-UTR
of IL-8 and regulates its mRNA stability in cancer.
Stage-dependent expression of Tip110 correlated with
the clinical outcomes of melanoma patients
To determine whether Tip110 expression would be cor-
related with clinical outcomes of melanoma patients, we
mined the transcriptomic profiling data and survival of
melanoma patients available in the TCGA database. The
median follow-up was 28.8 months in the analyzed
cohort that was composed of 455 (female = 180 and
male = 289) adult melanoma cancer patients (mean age:
58 years). Of all patients, 417 had no evidence of metas-
tasis (M = 0) while 24 patients had melanoma spread
from the primary site to other areas of the skin or under
the skin, or distant lymph nodes (M = 1) (Additional file
1: Figure S3A). The patients were further grouped based
on the melanoma stage, primary tumors (T) and regional
lymph nodes (N) (Additional file 1: Figure S3C-F). The
survival analysis using all patients in the database
showed that melanoma cancer patients with high Tip110
expression experienced worse overall survival rates
(Fig. 3a). Interestingly, when we ran the survival analysis
using patients at “stage 1” (n = 77); which was defined as
melanoma that is up to 2 mm thick, no lymph node in-
volvement and no distal metastasis; the patients with
low Tip110 expression experienced significantly worse
overall survival rates (Fig. 3b). We further analyzed the
overall survival of melanoma patients with respect to
IL-8 expression and found no significant difference in
the overall survival of either all patients or the patients
with “stage 1” tumors (Fig. 3c and d). However, there
was an inverse correlation on the overall survival be-
tween the Tip110 and IL-8 expression at the “stage 1”.
Recently, it has been reported that changes in serum
IL-8 levels during the immunotherapy treatment correl-
ate with overall survival in patients with metastatic mel-
anoma and non-small-cell lung cancer [11].
The results further demonstrated that TP53 expres-
sion, which is found to be regulated by Tip110 [3], at
“all stages” was not prognostic in malignant melanoma,
while at “stage 1” low expression of p53 showed poor
prognosis similar to the Tip110 in the same patient sub-
population (Fig. 3e and f). When we divided the samples
into two cohorts according to the TP53 status, we found
no significant correlation between TP53 status and
Tip110 expression (data not shown). 89% of all melan-
oma patients (n = 387) in our study expressed wild-type
TP53 (Additional file 1: Figure S3B). An early study has
shown that an increased level of TP53 protein does not
indicate an increased degree of malignancy in melan-
oma, but rather suggests a more favorable disease pro-
gression [12]. In addition, TP53 is also tightly regulated
Fig. 3 Correlation between Tip110, IL-8, TP53 expression and clinical outcome in melanoma patients. RNA-Seq data from TCGA were used to
assess the correlation between Tip110 expression and the overall survival (OS) probability (a and b), between IL-8 expression and the OS
probability (c and d), and between p53 expression and the OS probability (e and f). The OS probability was calculated separately for all stages
melanoma patients (a, c and e) and for stage 1 melanoma patients (b, d and f), which is defined as melanoma that is up to 2 mm thickness
(Additional file 1: Figure S3E). HR, hazard ratio. g. Tip110 expression in malignant melanoma cancer tissues. Images credit: Human Protein Atlas,
(www.proteinatlas.org) [13]. Images are available at the following URL: v16.proteinatlas.org/humancell. P.ID: patient identification number
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at the translational level through phosphorylation and
ubiquitination while the overall survival data were ob-
tained based on the TP53 mRNA level.
When we examined the Tip110 expression in melan-
oma patients’ tissues using the human protein atlas
online tool [13], we found several melanoma tumor sam-
ples show a high level of Tip110 expression. Interest-
ingly, some patients’ samples appeared to have a high
degree of heterogeneity in Tip110 expression throughout
a tissue section (Fig. 3g, subset). The overall findings
suggest the importance of differential expression of
Tip110 in melanoma tumorigenesis and its potential
prognostic value in patients’ clinical outcomes.
Conclusions
Our findings demonstrated the importance of the differ-
ential expression of Tip110 as a prognostic indicator of
melanoma tumorigenesis and the potential link to tumor
metastasis. Moreover, the roles of Tip110 in regulating
the production of IL-8 in melanoma suggest that the tar-
get genes or regulators of Tip110 may be suitable for
therapeutic intervention.
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